Covid-19 brought down the healthcare infrastructure of even the world’s most developed countries like the US, UK, France and more. The need to further enhance the healthcare infrastructure was the top most priority for state-owned as well as private players.
Investors pumped in more money just as the state got enthusiastic about the potential for healthtech.
Epharmacy startup Pharmeasy, patient relationship management solution Innovaccer, health and fitness chain Cultfit and surgical care startup Pristyn Care were all valued over $1 billion this year.
The valuation of PharmEasy is one of the notable developments of 2021 as India still does not have any clear guidelines on online delivery of medicines. The Delhi high court banned online sales of medicine across the country in 2018, but the government of India has shown excitement for digital delivery of health services as well medicines.
The Indian government rushed to roll out its National Digital Health Blueprint (NDHB) and Telemedicine Practice Guidelines last year to further enhance India’s healthcare infrastructure with the intervention of digital solutions.
“Embracing digital payments is a prime example of adaptability… Another example is telemedicine. We are already seeing several consultations without actually going to the clinic or hospital. Again, this is a positive sign. Can we think of business models to help further telemedicine across the world?,” Indian Prime Minister Narendra Modi said, in a Linkedin post published in April 2020.